On March 8, the company announced it was changing Johnson & Johnson Medical Devices to MedTech in order to “reflect the company’s global leadership as a medtech innovator,” according to the press release.
“Our business sits at the compelling intersection of medical devices and medical technology, and as the world’s most broadly based medtech company, we are committed to delivering breakthrough scientific innovation and reimagining health in an increasingly digital world,” Ashley McEvoy, executive vice president, worldwide chairman of Johnson & Johnson MedTech said.
The name change comes after the pharmaceutical giant announced the split into two companies on Nov. 12, with one public company being dedicated to medical devices and pharmaceuticals and another dedicated to consumer health products.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
